drugset / Trial / NCT01638663

Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)

NCT01638663

Phase 2 Completed 20 enrolled Regional Hospital Holstebro
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to investigate the effect of tolvaptan on renal water, sodium and potassium excretion, plasma concentration of vasoactive hormones,central blood pressure, pulse wave velocity (PWV) and augmentation index, basal and during inhibition of nitric oxide synthesis in healthy subjects.

Timeline

Start
2012-05
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tolvaptan Small molecule 15 mg Oral